[2]
Hurst SA,Appelgren KE,Kourtis AP, Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis. Expert review of anti-infective therapy. 2015 Feb;
[PubMed PMID: 25578882]
[3]
Worobey M,Gemmel M,Teuwen DE,Haselkorn T,Kunstman K,Bunce M,Muyembe JJ,Kabongo JM,Kalengayi RM,Van Marck E,Gilbert MT,Wolinsky SM, Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008 Oct 2;
[PubMed PMID: 18833279]
[4]
Mofenson LM, Mother-child HIV-1 transmission: Timing and determinants. Obstetrics and gynecology clinics of North America. 1997 Dec;
[PubMed PMID: 9430166]
[5]
Siberry GK, Preventing and managing HIV infection in infants, children, and adolescents in the United States. Pediatrics in review. 2014 Jul;
[PubMed PMID: 24986927]
[6]
Bispo S,Chikhungu L,Rollins N,Siegfried N,Newell ML, Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis. Journal of the International AIDS Society. 2017 Feb 22;
[PubMed PMID: 28362072]
Level 1 (high-level) evidence
[7]
Bansaccal N, Van der Linden D, Marot JC, Belkhir L. HIV-Infected Mothers Who Decide to Breastfeed Their Infants Under Close Supervision in Belgium: About Two Cases. Frontiers in pediatrics. 2020:8():248. doi: 10.3389/fped.2020.00248. Epub 2020 May 27
[PubMed PMID: 32537442]
Level 3 (low-level) evidence
[8]
Connor EM,Sperling RS,Gelber R,Kiselev P,Scott G,O'Sullivan MJ,VanDyke R,Bey M,Shearer W,Jacobson RL, Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. The New England journal of medicine. 1994 Nov 3;
[PubMed PMID: 7935654]
[9]
Shaffer N,Chuachoowong R,Mock PA,Bhadrakom C,Siriwasin W,Young NL,Chotpitayasunondh T,Chearskul S,Roongpisuthipong A,Chinayon P,Karon J,Mastro TD,Simonds RJ, Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet (London, England). 1999 Mar 6;
[PubMed PMID: 10459957]
Level 1 (high-level) evidence
[10]
Jamieson DJ,Sibailly TS,Sadek R,Roels TH,Ekpini ER,Boni-Ouattara E,Karon JM,Nkengasong J,Greenberg AE,Wiktor SZ, HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire. Journal of acquired immune deficiency syndromes (1999). 2003 Dec 1;
[PubMed PMID: 14615662]
[11]
Jackson JB,Musoke P,Fleming T,Guay LA,Bagenda D,Allen M,Nakabiito C,Sherman J,Bakaki P,Owor M,Ducar C,Deseyve M,Mwatha A,Emel L,Duefield C,Mirochnick M,Fowler MG,Mofenson L,Miotti P,Gigliotti M,Bray D,Mmiro F, Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet (London, England). 2003 Sep 13;
[PubMed PMID: 13678973]
Level 1 (high-level) evidence
[12]
John GC,Nduati RW,Mbori-Ngacha DA,Richardson BA,Panteleeff D,Mwatha A,Overbaugh J,Bwayo J,Ndinya-Achola JO,Kreiss JK, Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. The Journal of infectious diseases. 2001 Jan 15;
[PubMed PMID: 11120927]
[13]
Kempton J,Hill A,Levi JA,Heath K,Pozniak A, Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries. Journal of virus eradication. 2019 Apr 1;
[PubMed PMID: 31191912]
[14]
Nesheim SR,Wiener J,Fitz Harris LF,Lampe MA,Weidle PJ, Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978-2013. Journal of acquired immune deficiency syndromes (1999). 2017 Dec 15;
[PubMed PMID: 28991886]
[15]
Peters H,Francis K,Sconza R,Horn A,S Peckham C,Tookey PA,Thorne C, UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Feb 15;
[PubMed PMID: 28174911]
[16]
Nesheim SR,FitzHarris LF,Lampe MA,Gray KM, Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States. Public health reports (Washington, D.C. : 1974). 2018 Nov;
[PubMed PMID: 30265616]
[17]
Peters H,Thorne C,Tookey PA,Byrne L, National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt? HIV medicine. 2018 Apr;
[PubMed PMID: 29336508]
[18]
Nesheim SR,FitzHarris LF,Mahle Gray K,Lampe MA, Epidemiology of Perinatal HIV Transmission in the United States in the Era of Its Elimination. The Pediatric infectious disease journal. 2019 Jun;
[PubMed PMID: 30724833]
[19]
Maartens G,Celum C,Lewin SR, HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet (London, England). 2014 Jul 19;
[PubMed PMID: 24907868]
[21]
Ahmad N, Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells. Life sciences. 2011 May 23;
[PubMed PMID: 20888841]
[22]
Little K,Thorne C,Luo C,Bunders M,Ngongo N,McDermott P,Newell ML, Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Current HIV research. 2007 Mar;
[PubMed PMID: 17346131]
[24]
Al-Husaini AM, Role of placenta in the vertical transmission of human immunodeficiency virus. Journal of perinatology : official journal of the California Perinatal Association. 2009 May;
[PubMed PMID: 19020526]
[25]
Ehrnst A,Lindgren S,Dictor M,Johansson B,Sönnerborg A,Czajkowski J,Sundin G,Bohlin AB, HIV in pregnant women and their offspring: evidence for late transmission. Lancet (London, England). 1991 Jul 27
[PubMed PMID: 1676777]
[26]
Rouzioux C,Costagliola D,Burgard M,Blanche S,Mayaux MJ,Griscelli C,Valleron AJ, Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. American journal of epidemiology. 1995 Dec 15
[PubMed PMID: 7503054]
[27]
Bornstein MH, Qualities of color vision in infancy. Journal of experimental child psychology. 1975 Jun
[PubMed PMID: 1176886]
[28]
King CC,Ellington SR,Kourtis AP, The role of co-infections in mother-to-child transmission of HIV. Current HIV research. 2013 Jan
[PubMed PMID: 23305198]
[29]
Landesman SH,Kalish LA,Burns DN,Minkoff H,Fox HE,Zorrilla C,Garcia P,Fowler MG,Mofenson L,Tuomala R, Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. The New England journal of medicine. 1996 Jun 20
[PubMed PMID: 8628356]
[30]
Kourtis AP,Bulterys M,Nesheim SR,Lee FK, Understanding the timing of HIV transmission from mother to infant. JAMA. 2001 Feb 14
[PubMed PMID: 11176886]
Level 3 (low-level) evidence
[31]
Van de Perre P,Simonon A,Msellati P,Hitimana DG,Vaira D,Bazubagira A,Van Goethem C,Stevens AM,Karita E,Sondag-Thull D, Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. The New England journal of medicine. 1991 Aug 29
[PubMed PMID: 1812850]
[32]
Van de Perre P,Lepage P,Homsy J,Dabis F, Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1992 Sep
[PubMed PMID: 1445596]
[33]
Lehman DA,Farquhar C, Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Reviews in medical virology. 2007 Nov-Dec
[PubMed PMID: 17542053]
[34]
Shen R,Smythies LE,Clements RH,Novak L,Smith PD, Dendritic cells transmit HIV-1 through human small intestinal mucosa. Journal of leukocyte biology. 2010 Apr
[PubMed PMID: 20007245]
[36]
Lapenta C,Boirivant M,Marini M,Santini SM,Logozzi M,Viora M,Belardelli F,Fais S, Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. European journal of immunology. 1999 Apr
[PubMed PMID: 10229087]
[37]
Marno K,Al'Zoubi L,Pearson M,Posch M,McKnight Á,Wheeler AP, The evolution of structured illumination microscopy in studies of HIV. Methods (San Diego, Calif.). 2015 Oct 15;
[PubMed PMID: 26071977]
[38]
Moonim MT,Alarcon L,Freeman J,Mahadeva U,van der Walt JD,Lucas SB, Identifying HIV infection in diagnostic histopathology tissue samples--the role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: a 3-year analysis. Histopathology. 2010 Mar
[PubMed PMID: 20459560]
[39]
Gilleece DY,Tariq DS,Bamford DA,Bhagani DS,Byrne DL,Clarke DE,Clayden MP,Lyall DH,Metcalfe DR,Palfreeman DA,Rubinstein DL,Sonecha MS,Thorley DL,Tookey DP,Tosswill MJ,Utting MD,Welch DS,Wright MA, British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018. HIV medicine. 2019 Mar
[PubMed PMID: 30869192]
[40]
Abdollahi A,Saffar H, The Diagnosis of HIV Infection in Infants and Children. Iranian journal of pathology. 2016 Spring
[PubMed PMID: 27499768]
[41]
Lilian RR,Kalk E,Bhowan K,Berrie L,Carmona S,Technau K,Sherman GG, Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. Journal of clinical microbiology. 2012 Jul
[PubMed PMID: 22518871]
[42]
Burgard M,Blanche S,Jasseron C,Descamps P,Allemon MC,Ciraru-Vigneron N,Floch C,Heller-Roussin B,Lachassinne E,Mazy F,Warszawski J,Rouzioux C, Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. The Journal of pediatrics. 2012 Jan
[PubMed PMID: 21868029]
[43]
Havens PL,Mofenson LM, Evaluation and management of the infant exposed to HIV-1 in the United States. Pediatrics. 2009 Jan
[PubMed PMID: 19117880]
[44]
Foster C,Bamford A,Turkova A,Welch S,Klein N, Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV. HIV medicine. 2017 Feb
[PubMed PMID: 27385585]
[45]
Kapogiannis BG,Soe MM,Nesheim SR,Abrams EJ,Carter RJ,Farley J,Palumbo P,Koenig LJ,Bulterys M, Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Nov
[PubMed PMID: 22002982]
[46]
Mirani G,Williams PL,Chernoff M,Abzug MJ,Levin MJ,Seage GR 3rd,Oleske JM,Purswani MU,Hazra R,Traite S,Zimmer B,Van Dyke RB, Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Dec 15
[PubMed PMID: 26270680]
[47]
Violari A,Cotton MF,Gibb DM,Babiker AG,Steyn J,Madhi SA,Jean-Philippe P,McIntyre JA, Early antiretroviral therapy and mortality among HIV-infected infants. The New England journal of medicine. 2008 Nov 20
[PubMed PMID: 19020325]
[48]
Kuhn L,Paximadis M,Da Costa Dias B,Loubser S,Strehlau R,Patel F,Shiau S,Coovadia A,Abrams EJ,Tiemessen CT, Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. PloS one. 2018
[PubMed PMID: 29649264]
[49]
Tagarro A,Chan M,Zangari P,Ferns B,Foster C,De Rossi A,Nastouli E,Muñoz-Fernández MA,Gibb D,Rossi P,Giaquinto C,Babiker A,Fortuny C,Freguja R,Cotugno N,Judd A,Noguera-Julian A,Navarro ML,Mellado MJ,Klein N,Palma P,Rojo P, Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children. Journal of acquired immune deficiency syndromes (1999). 2018 Oct 1
[PubMed PMID: 30211778]
[50]
Nesheim S,Taylor A,Lampe MA,Kilmarx PH,Fitz Harris L,Whitmore S,Griffith J,Thomas-Proctor M,Fenton K,Mermin J, A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics. 2012 Oct;
[PubMed PMID: 22945404]
[51]
Revised surveillance case definition for HIV infection--United States, 2014. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2014 Apr 11
[PubMed PMID: 24717910]
Level 3 (low-level) evidence
[53]
Kuhn L,Shiau S, The pharmacological treatment of acute HIV infections in neonates. Expert review of clinical pharmacology. 2017 Dec
[PubMed PMID: 29098898]
[54]
Mofenson LM,Brady MT,Danner SP,Dominguez KL,Hazra R,Handelsman E,Havens P,Nesheim S,Read JS,Serchuck L,Van Dyke R, Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2009 Sep 4
[PubMed PMID: 19730409]
[55]
Violari A,Lindsey JC,Hughes MD,Mujuru HA,Barlow-Mosha L,Kamthunzi P,Chi BH,Cotton MF,Moultrie H,Khadse S,Schimana W,Bobat R,Purdue L,Eshleman SH,Abrams EJ,Millar L,Petzold E,Mofenson LM,Jean-Philippe P,Palumbo P, Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. The New England journal of medicine. 2012 Jun 21
[PubMed PMID: 22716976]
[56]
Ruel TD,Kakuru A,Ikilezi G,Mwangwa F,Dorsey G,Rosenthal PJ,Charlebois E,Havlir D,Kamya M,Achan J, Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. Journal of acquired immune deficiency syndromes (1999). 2014 Apr 15
[PubMed PMID: 24326597]
Level 1 (high-level) evidence
[57]
Tsiang M,Jones GS,Goldsmith J,Mulato A,Hansen D,Kan E,Tsai L,Bam RA,Stepan G,Stray KM,Niedziela-Majka A,Yant SR,Yu H,Kukolj G,Cihlar T,Lazerwith SE,White KL,Jin H, Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Antimicrobial agents and chemotherapy. 2016 Dec
[PubMed PMID: 27645238]
[58]
Oliveira M,Ibanescu RI,Anstett K,Mésplède T,Routy JP,Robbins MA,Brenner BG, Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir. Retrovirology. 2018 Aug 17
[PubMed PMID: 30119633]
[59]
Neogi U,Singh K,Aralaguppe SG,Rogers LC,Njenda DT,Sarafianos SG,Hejdeman B,Sönnerborg A, Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes. AIDS (London, England). 2018 Feb 20
[PubMed PMID: 29239896]
[60]
Mulenga V,Musiime V,Kekitiinwa A,Cook AD,Abongomera G,Kenny J,Chabala C,Mirembe G,Asiimwe A,Owen-Powell E,Burger D,McIlleron H,Klein N,Chintu C,Thomason MJ,Kityo C,Walker AS,Gibb DM, Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. The Lancet. Infectious diseases. 2016 Feb
[PubMed PMID: 26481928]
Level 1 (high-level) evidence
[61]
Van Dyke RB,Wang L,Williams PL, Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. The Journal of infectious diseases. 2008 Dec 1
[PubMed PMID: 19000014]
[62]
Moyle GJ,Sabin CA,Cartledge J,Johnson M,Wilkins E,Churchill D,Hay P,Fakoya A,Murphy M,Scullard G,Leen C,Reilly G, A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS (London, England). 2006 Oct 24
[PubMed PMID: 17053350]
Level 2 (mid-level) evidence
[63]
Carr A,Workman C,Smith DE,Hoy J,Hudson J,Doong N,Martin A,Amin J,Freund J,Law M,Cooper DA, Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002 Jul 10
[PubMed PMID: 12095385]
Level 1 (high-level) evidence
[64]
DeJesus E,Rockstroh JK,Lennox JL,Saag MS,Lazzarin A,Zhao J,Wan H,Rodgers AJ,Walker ML,Miller M,DiNubile MJ,Nguyen BY,Teppler H,Leavitt R,Sklar P, Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. HIV clinical trials. 2012 Jul-Aug
[PubMed PMID: 22849964]
[65]
Green H,Gibb DM,Walker AS,Pillay D,Butler K,Candeias F,Castelli-Gattinara G,Compagnucci A,Della Negra M,de Rossi A,Feiterna-Sperling C,Giaquinto C,Harper L,Levy J,Saidi Y,Wintergerst U, Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS (London, England). 2007 May 11
[PubMed PMID: 17457088]
[66]
Sax PE,Tierney C,Collier AC,Fischl MA,Mollan K,Peeples L,Godfrey C,Jahed NC,Myers L,Katzenstein D,Farajallah A,Rooney JF,Ha B,Woodward WC,Koletar SL,Johnson VA,Geiseler PJ,Daar ES, Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. The New England journal of medicine. 2009 Dec 3
[PubMed PMID: 19952143]
[67]
Smith KY,Patel P,Fine D,Bellos N,Sloan L,Lackey P,Kumar PN,Sutherland-Phillips DH,Vavro C,Yau L,Wannamaker P,Shaefer MS, Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. AIDS (London, England). 2009 Jul 31
[PubMed PMID: 19542866]
Level 1 (high-level) evidence
[68]
Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial. Lancet (London, England). 2002 Mar 2
[PubMed PMID: 11888583]
Level 1 (high-level) evidence
[69]
Infant feeding and transmission of human immunodeficiency virus in the United States. Pediatrics. 2013 Feb;
[PubMed PMID: 23359577]
[70]
King CC,Kourtis AP,Persaud D,Nelson JA,Ziemniak C,Hudgens MG,Tegha G,Chasela CS,Jamieson DJ,van der Horst CM, Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding. AIDS (London, England). 2015 Sep 24
[PubMed PMID: 26153671]
[71]
Gaur AH,Freimanis-Hance L,Dominguez K,Mitchell C,Menezes J,Mussi-Pinhata MM,Peixoto MF,Alarcon J,Coelho DF,Read JS, Knowledge and practice of prechewing/prewarming food by HIV-infected women. Pediatrics. 2011 May
[PubMed PMID: 21482608]
[72]
Premastication of food by caregivers of HIV-exposed children--nine U.S. sites, 2009-2010. MMWR. Morbidity and mortality weekly report. 2011 Mar 11
[PubMed PMID: 21389930]
[73]
Hafeez S,Salami O,Alvarado M,Maldonado M,Purswani M,Hagmann S, Infant feeding practice of premastication: an anonymous survey among human immunodeficiency virus-infected mothers. Archives of pediatrics & adolescent medicine. 2011 Jan
[PubMed PMID: 21199989]
Level 3 (low-level) evidence